Abstract
This article briefly reviews the current status of bronchial artery chemoinfusion therapy, and short- and long-term results, especially for unresectable non-small cell lung cancers. The rationale of bronchial artery chemoinfusion therapy, selection of patients and chemotherapy agents, and pretreatment evaluation are described. The technical issues involved in the procedure, including bronchial artery anatomy, angiographic technique, infusion of anticancer agents, and complications are also outlined. The promising tumor response rate indicates that bronchial artery chemoinfusion is effective in cytoreduction in advanced lung cancer, and can play an important role in multimodality management of non-small cell lung cancer.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call